KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Clover Health Investments (CLOV) Cost of Revenue (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Cost of Revenue for 5 consecutive years, with $413.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 70.13% year-over-year to $413.5 million, compared with a TTM value of $1.6 billion through Dec 2025, up 55.85%, and an annual FY2025 reading of $1.6 billion, up 55.85% over the prior year.
  • Cost of Revenue was $413.5 million for Q4 2025 at Clover Health Investments, down from $423.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $861.7 million in Q1 2022 and bottomed at -$2.6 billion in Q4 2022.
  • Average Cost of Revenue over 5 years is $246.8 million, with a median of $378.0 million recorded in 2025.
  • The sharpest move saw Cost of Revenue surged 301.89% in 2022, then tumbled 68.11% in 2023.
  • Year by year, Cost of Revenue stood at $436.3 million in 2021, then tumbled by 686.77% to -$2.6 billion in 2022, then surged by 87.35% to -$323.8 million in 2023, then skyrocketed by 175.06% to $243.0 million in 2024, then skyrocketed by 70.13% to $413.5 million in 2025.
  • Business Quant data shows Cost of Revenue for CLOV at $413.5 million in Q4 2025, $423.5 million in Q3 2025, and $378.0 million in Q2 2025.